| Financial Year |
March 31 2023 |
| Monetary Funds |
169,171,465.33 |
| Held-for-trading Financial Assets |
1,664,747.04 |
| Notes Receivable |
122,314.70 |
| Accounts Receivable |
94,875,292.55 |
| Advances to Suppliers |
28,363,416.16 |
| Other Receivables |
368,459,194.85 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
5,275,794,240.31 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
152,259,132.88 |
| Total Current Assets |
6,090,709,803.82 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
7,996,642.66 |
| Investment Properties |
10,753,028,697.24 |
| Fixed Assetes |
2,791,467,775.95 |
| Under-construction Projects |
13,347,051.05 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
824,404,230.16 |
| R&D expenses |
-- |
| Goodwill |
1,072,953,194.34 |
| Long-Term Deferred and Prepaid Expenses |
99,340,629.49 |
| Deferred Income Tax Assets |
51,292,889.65 |
| Other Non-Current Assets |
7,615,538.41 |
| Sub-Total of Non-Current Assets |
21,668,246,062.74 |
| Total Assets |
27,758,955,866.56 |
| Short-Term Loans |
8,011,977.78 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
622,667,820.78 |
| Accounts Received In Advance |
99,362,178.31 |
| Employee Compensation Payable |
179,236,233.89 |
| Taxes Payable |
1,322,592,383.87 |
| Interest Payable |
-- |
| Dividend Payable |
13,648,244.00 |
| Other payables |
1,030,296,444.57 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
356,373,624.18 |
| Other Current Liabilities |
599,937,281.54 |
| Sub-Total of Current Liabilities |
4,884,449,850.06 |
| Long-term Loans |
5,183,812,997.96 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
887,848,174.73 |
| Special Payable |
-- |
| Estimatied Liabilities |
2,232,422,160.12 |
| Deferred Income Tax Liabilities |
1,889,975,643.47 |
| Other Non-Current Liabilities |
606,724,327.71 |
| Sub-Total of Non-Current Liabilities |
11,130,758,979.08 |
| Total Liabilities |
16,015,208,829.14 |
| Paid-In Capital(Or Share Stock) |
19,163,777,335.00 |
| Capital Surplus |
15,756,243,102.56 |
| Surplus Reserve |
168,038,335.63 |
| LESS:Treasury Stock |
16,839,544,250.62 |
| Undistributed Profits |
-7,440,067,171.04 |
| Minority Stockholder's Interest |
493,237,064.92 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,250,509,972.50 |
| Owner's Equity（Stockholder's Equity） |
11,743,747,037.42 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
27,758,955,866.56 |
